136 related articles for article (PubMed ID: 38331308)
1. A pathogenic role for brain-derived neurotrophic factor (BDNF) in fibrous dysplasia of bone.
Palmisano B; Farinacci G; Campolo F; Tavanti C; Stefano A; Donsante S; Ippolito E; Giannicola G; Venneri MA; Corsi A; Riminucci M
Bone; 2024 Apr; 181():117047. PubMed ID: 38331308
[TBL] [Abstract][Full Text] [Related]
2. RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease.
Palmisano B; Spica E; Remoli C; Labella R; Di Filippo A; Donsante S; Bini F; Raimondo D; Marinozzi F; Boyde A; Robey P; Corsi A; Riminucci M
J Bone Miner Res; 2019 Dec; 34(12):2171-2182. PubMed ID: 31295366
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.
Saggio I; Remoli C; Spica E; Cersosimo S; Sacchetti B; Robey PG; Holmbeck K; Cumano A; Boyde A; Bianco P; Riminucci M
J Bone Miner Res; 2014 Nov; 29(11):2357-68. PubMed ID: 24764158
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of "Giant Osteoclasts" and Pathogenetic Implications.
Corsi A; Palmisano B; Spica E; Di Filippo A; Coletta I; Dello Spedale Venti M; Labella R; Fabretti F; Donsante S; Remoli C; Serafini M; Riminucci M
Calcif Tissue Int; 2020 Dec; 107(6):603-610. PubMed ID: 32875378
[TBL] [Abstract][Full Text] [Related]
6. Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo.
Ai LS; Sun CY; Wang YD; Zhang L; Chu ZB; Qin Y; Gao F; Yan H; Guo T; Chen L; Yang D; Hu Y
Int J Cancer; 2013 Sep; 133(5):1074-84. PubMed ID: 23420490
[TBL] [Abstract][Full Text] [Related]
7. Expression of an active Gα
Zhao X; Deng P; Iglesias-Bartolome R; Amornphimoltham P; Steffen DJ; Jin Y; Molinolo AA; de Castro LF; Ovejero D; Yuan Q; Chen Q; Han X; Bai D; Taylor SS; Yang Y; Collins MT; Gutkind JS
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E428-E437. PubMed ID: 29282319
[TBL] [Abstract][Full Text] [Related]
8. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.
de Castro LF; Burke AB; Wang HD; Tsai J; Florenzano P; Pan KS; Bhattacharyya N; Boyce AM; Gafni RI; Molinolo AA; Robey PG; Collins MT
J Bone Miner Res; 2019 Feb; 34(2):290-294. PubMed ID: 30496606
[TBL] [Abstract][Full Text] [Related]
9. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Robinson C; Collins MT; Boyce AM
Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
[TBL] [Abstract][Full Text] [Related]
10. RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia.
Liu Z; Yin Y; Wang Z; Xie L; Deng P; Wang D; Ji N; Zhao H; Han X; Chen Q; Chung CH; Bai D; Zhao X
Bone; 2022 Mar; 156():116301. PubMed ID: 34952228
[TBL] [Abstract][Full Text] [Related]
11. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Majoor BCJ; Geels RES; Appelman-Dijkstra NM; Bravenboer N
Bone; 2023 Apr; 169():116679. PubMed ID: 36652988
[TBL] [Abstract][Full Text] [Related]
12. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone.
Raimondo D; Remoli C; Astrologo L; Burla R; La Torre M; Vernì F; Tagliafico E; Corsi A; Del Giudice S; Persichetti A; Giannicola G; Robey PG; Riminucci M; Saggio I
PLoS One; 2020; 15(1):e0227279. PubMed ID: 31999703
[TBL] [Abstract][Full Text] [Related]
13. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
Pollandt K; Engels C; Kaiser E; Werner M; Delling G
Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
[TBL] [Abstract][Full Text] [Related]
15. Treatment of fibrous dysplasia: focus on denosumab.
Huzum B; Antoniu S; Dragomir R
Expert Opin Biol Ther; 2022 Mar; 22(3):397-405. PubMed ID: 34964677
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myeloma.
Sun CY; Chu ZB; She XM; Zhang L; Chen L; Ai LS; Hu Y
Int J Cancer; 2012 Feb; 130(4):827-36. PubMed ID: 21400510
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of BDNF in multiple myeloma blocks osteoclastogenesis via down-regulated stroma-derived RANKL expression both in vitro and in vivo.
Ai LS; Sun CY; Zhang L; Zhou SC; Chu ZB; Qin Y; Wang YD; Zeng W; Yan H; Guo T; Chen L; Yang D; Hu Y
PLoS One; 2012; 7(10):e46287. PubMed ID: 23077504
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
[TBL] [Abstract][Full Text] [Related]
19. RANKL inhibition reduces lesional cellularity and Gα
de Castro LF; Whitlock JM; Michel Z; Pan K; Taylor J; Szymczuk V; Boyce B; Martin D; Kram V; Galisteo R; Melikov K; Chernomordik LV; Collins MT; Boyce AM
Bone Res; 2024 Feb; 12(1):10. PubMed ID: 38378678
[TBL] [Abstract][Full Text] [Related]
20. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression.
Riminucci M; Kuznetsov SA; Cherman N; Corsi A; Bianco P; Gehron Robey P
Bone; 2003 Sep; 33(3):434-42. PubMed ID: 13678786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
